AxoGen Inc. | Key People and Executives
Karen L. Zaderej
Chairman, President & Chief Executive Officer
Amy Wendell
Lead Director
Lisa N. Colleran
Director
Gregory G. Freitag
Director & Senior VP-Business Development
Amy A. McBride-Wendell
Independent Director
Robert James Rudelius
Independent Director
Guido J. Neels
Independent Director
Mark Stephen Gold
Independent Director
Karen L. Zaderej
Chairman, President & Chief Executive Officer
Mike Donovan
Vice President-Operations
Peter J. Mariani
Chief Financial Officer
Angelo G. Scopelianos
Vice President-Research & Development
Ivica Ducic
Medical Director-Clinical & Translational Sciences
Jon S. Gingrich
Chief Commercial Officer
Erick Wayne DeVinney
Vice President-Clinical & Translational Sciences
Amy Wendell
Lead Director
Lisa N. Colleran
Director
Gregory G. Freitag
Director & Senior VP-Business Development
David K. Hansen
Treasurer & Vice President-Finance
Kevin Leach
Vice President-Marketing
Shawn F. McCarrey
Senior Vice President-Sales
Kaila P. Krum
VP-Investor Relations & Corporate Development
Mark Louis Friedman
VP-Regulatory Affairs & Quality Assurance
Amy A. McBride-Wendell
Independent Director
Robert James Rudelius
Independent Director
Guido J. Neels
Independent Director
Mark Stephen Gold
Independent Director
| Address |
13631 Progress Boulevard
Alachua Florida 32615
United States
|
|
Employees
|
- |
| Website |
http://www.axogeninc.com |
| Updated |
07/08/2019 |
| AxoGen, Inc. engages in the development and market of surgical solutions for peripheral nerves. It also provide products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. Its products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. |
